STOCK TITAN

Notifications

Limited Time Offer! Get Platinum at the Gold price until January 31, 2026!

Sign up now and unlock all premium features at an incredible discount.

Read more on the Pricing page

Lifecore Biomedical to Present at Stephens Annual Investment Conference

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences

Lifecore Biomedical (NASDAQ: LFCR) has announced its participation in the upcoming Stephens Annual Investment Conference, scheduled for November 19-21, 2024, in Nashville, Tennessee. The company's president and CEO, Paul Josephs, will be featured in a fireside chat on Tuesday, November 19, 2024, at 2:00 p.m. Central time at the Grand Hyatt Nashville. Additionally, Lifecore management will be available for one-on-one meetings during the conference.

Loading...
Loading translation...

Positive

  • None.

Negative

  • None.

CHASKA, Minn., Nov. 12, 2024 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: LFCR) (“Lifecore”), a fully integrated contract development and manufacturing organization (“CDMO”), today announced that Paul Josephs, the company’s president and chief executive officer, will be a featured speaker in a fireside chat at the upcoming Stephens Annual Investment Conference. The conference is being held November 19-21, 2024, in Nashville, Tennessee.

Details regarding Lifecore’s participation are as follows:

  • Stephens Annual Investment Conference
    Details: Mr. Josephs will be a featured speaker in a fireside chat and Lifecore management will participate in 1-on-1 meetings
    Conference Dates: November 19-21, 2024
    Fireside Chat Timing: 2:00 p.m. Central on Tuesday, November 19, 2024
    Location: Grand Hyatt Nashville

About Lifecore Biomedical

Lifecore Biomedical, Inc. (Nasdaq: LFCR) is a fully integrated contract development and manufacturing organization (CDMO) that offers highly differentiated capabilities in the development, fill and finish of sterile injectable pharmaceutical products in syringes, vials, and cartridges, including complex formulations. As a leading manufacturer of premium, injectable-grade hyaluronic acid, Lifecore brings more than 40 years of expertise as a partner for global and emerging biopharmaceutical and biotechnology companies across multiple therapeutic categories to bring their innovations to market. For more information about the company, visit Lifecore’s website at www.lifecore.com.


FAQ

When is Lifecore Biomedical (LFCR) presenting at the Stephens Annual Investment Conference 2024?

Lifecore Biomedical will present on Tuesday, November 19, 2024, at 2:00 p.m. Central time during a fireside chat at the Stephens Annual Investment Conference.

Where is the Stephens Annual Investment Conference 2024 featuring Lifecore (LFCR) being held?

The conference is being held at the Grand Hyatt Nashville, Tennessee, from November 19-21, 2024.

What type of presentation will Lifecore Biomedical (LFCR) give at the Stephens Conference?

Lifecore's CEO Paul Josephs will participate in a fireside chat presentation, and management will be available for one-on-one meetings.
Lifecore Biomedical Inc

NASDAQ:LFCR

LFCR Rankings

LFCR Latest News

LFCR Latest SEC Filings

LFCR Stock Data

295.98M
36.71M
1.99%
76.48%
6.93%
Drug Manufacturers - Specialty & Generic
Pharmaceutical Preparations
Link
United States
CHASKA